These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

14 related articles for article (PubMed ID: 37443486)

  • 1. Exploring the Communication of the SASP: Dynamic, Interactive, and Adaptive Effects on the Microenvironment.
    Giroud J; Bouriez I; Paulus H; Pourtier A; Debacq-Chainiaux F; Pluquet O
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a ubiquitin-proteasome system gene signature for prognostic prediction and immune microenvironment evaluation in hepatocellular carcinoma.
    Liu ZY; Li YH; Zhang QK; Li BW; Xin L
    J Cancer Res Clin Oncol; 2023 Nov; 149(14):13363-13382. PubMed ID: 37490101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The complementarity of DDR, nucleic acids and anti-tumour immunity.
    Kornepati AVR; Rogers CM; Sung P; Curiel TJ
    Nature; 2023 Jul; 619(7970):475-486. PubMed ID: 37468584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in Transcription Factors Biomarkers and Targeted Therapies Focusing on Epithelial-Mesenchymal Transition.
    Chuang KT; Chiou SS; Hsu SH
    Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and molecular basis for cellular senescence.
    Barrett JC; Annab LA; Futreal PA
    Adv Exp Med Biol; 1993; 330():27-43. PubMed ID: 8368137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-Omics Mining of lncRNAs with Biological and Clinical Relevance in Cancer.
    Salido-Guadarrama I; Romero-Cordoba SL; Rueda-Zarazua B
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
    Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
    Front Immunol; 2022; 13():891175. PubMed ID: 35990668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mitochondrial function-related LncRNA signature predicts prognosis and immune microenvironment for breast cancer.
    Wang Y; Gao S; Xu Y; Tang Z; Liu S
    Sci Rep; 2023 Mar; 13(1):3918. PubMed ID: 36890266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and validation of a novel cellular senescence-related lncRNA prognostic signature for predicting immunotherapy response in stomach adenocarcinoma.
    Zeng C; Liu Y; He R; Lu X; Dai Y; Qi G; Liu J; Deng J; Lu W; Jin J; Liu Q
    Front Genet; 2022; 13():935056. PubMed ID: 36092903
    [No Abstract]   [Full Text] [Related]  

  • 10. The current advances of lncRNAs in breast cancer immunobiology research.
    Fonseca-Montaño MA; Vázquez-Santillán KI; Hidalgo-Miranda A
    Front Immunol; 2023; 14():1194300. PubMed ID: 37342324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-omics analysis revealing a senescence-relevant lncRNAs signature for the assessment of response to immunotherapy for breast cancer.
    Yu Z; Zhu Y; Ji J
    Medicine (Baltimore); 2023 Jul; 102(28):e34287. PubMed ID: 37443486
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.